- Review COVID-19 background as it relates to secondary and co-infections
- Understand the current limitations of traditional methods in diagnosing secondary and co-infections
- Identify appropriate COVID-19 patients at risk for secondary or co-infections to be tested with T2 Biosystems’ panels
- Learn about T2 Biosystems response to COVID-19
About the speaker:
Sandy Estrada, PharmD., Vice President, Medical Affairs, T2 Biosystems. Sandy previously held the position of Infectious Diseases Clinical Pharmacist for Lee Health in Fort Myers, Florida for 13 years where she served as the Co-Director of Antimicrobial Stewardship and Director of the ID Pharmacy Residency Program.